Curr Cancer Drug Targets. 2008 Dec;8(8):666-75.

Anticancer immunotherapy in combination with proapoptotic therapy.

Bruserud Ø, Ersvaer E, Olsnes A, Gjertsen BT.

Hematology. 2008 Dec;13(6):329-32.

Circulating T cells derived from acute leukemia patients with severe therapy-induced cytopenia express a wide range of chemokine receptors.

Olsnes AM, Ersvaer E, Ryningen A, Bruserud O.

Expert Opin Investig Drugs. 2008 Nov;17(11):1623-33.

In vivo biological effects of ATRA in the treatment of AML.

Ryningen A, Stapnes C, Paulsen K, Lassalle P, Gjertsen BT, Bruserud O.

J Interferon Cytokine Res. 2008 May;28(5):297-310.

In vitro induction of a dendritic cell phenotype in primary human acute myelogenous leukemia (AML) blasts alters the chemokine release profile and increases the levels of T cell chemotactic CCL17 and CCL22.

Olsnes AM, Ryningen A, Ersvaer E, Bruserud Ø.

Transfusion. 2008 May;48(5):877-83. Epub 2008 Feb 21.

Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.

Akkök CA, Liseth K, Nesthus I, Løkeland T, Tefre K, Bruserud O, Abrahamsen JF.

Platelets. 2008 Mar;19(2):155-9.

Platelet-released supernatants enhance hematopoietic stem cell proliferation in vitro.

Foss B, Bruserud O, Hervig T.

Oncogene. 2008 Jun 19;27(27):3765-79. doi: 10.1038/onc.2008.16. Epub 2008 Feb 11.

Review: genetic models of acute myeloid leukaemia.

McCormack E, Bruserud O, Gjertsen BT.

Thromb Haemost. 2008 Jan;99(1):27-37.

Platelet functions and clinical effects in acute myelogenous leukemia.

Foss B, Bruserud O.

Blood. 2008 Mar 1;111(5):2866-77. Epub 2008 Jan 8.

Abolition of stress-induced protein synthesis sensitizes leukemia cells to anthracycline-induced death.

Gausdal G, Gjertsen BT, McCormack E, Van Damme P, Hovland R, Krakstad C, Bruserud Ø, Gevaert K, Vandekerckhove J, Døskeland SO.

Leukemia. 2008 Feb;22(2):287-93. Epub 2007 Oct 18.

Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels.

Hatfield KJ, Hovland R, Øyan AM, Kalland KH, Ryningen A, Gjertsen BT, Bruserud Ø.